High myocardial 18F-FDG uptake after chemotherapy in the presence of left ventricular dysfunction as well as 3-month later with no left ventricular dysfunction

Authors

  • Chang Lim Hyun Department of Pathology, School of Medicine, Jeju National University, Jeju, Republic of Korea
  • Heesung Song Department of Nuclear Medicine, School of Medicine, Jeju National University, Jeju, Republic of Korea
  • Joon Hyouk Choi Division of Cardiology, Department of Internal Medicine, School of Medicine, Jeju National University, Jeju, Republic of Korea
Abstract:

Diffusely increased glucose metabolic activity in the right and left ventricles using 2-deoxy-2-(F-18) fluoro-D-glucose positron emission tomography/computed tomography (18F-FDGPET/CT) and global left ventricular hypokinesia at echocardiography can be evident in acute myocarditis. But, there has been no case report that the ventricular 18F-FDGuptake remains unchanged even after recovery of ventricular hypokinesia. A 60-year-old female with primary pleural effusion lymphoma underwent echocardiography and electrocardiography due to fever and elevated cardiac marker after chemotherapy. The electrocardiography showed global hypokinesia suggesting heart failure and the managements were performed. After 20 days 18F-FDGPET/CT for assessing the extent of lymphoma demonstrated that newly appeared high 18F-FDGuptake in the myocardium suggesting pathologic lesions. To evaluate malignancy a cardiac biopsy was performed. Myocarditis was confirmed pathologically. Three months later, improved ventricular function was confirmed by echocardiography, but the metabolic activity in the ventricles was not decreased at follow-up 18F-FDGPET/CT.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

echocardiographic assessment of inappropriate left ventricular mass and left ventricular hypertrophy in patients with diastolic dysfunction

background: early diagnosis of left ventricular mass (lvm) inappropriateness and left ventricular hypertrophy   (lvh) can result in preventing diastolic left ventricular dysfunction and its related morbidity and mortality. this study was performed to determine if diastolic dysfunction   is associated with lvh and inappropriate lvm. methods: one hundred   and twenty five uncomplicated hypertensi...

full text

Tolvaptan improves left ventricular dysfunction after myocardial infarction in rats.

BACKGROUND Arginine vasopressin, which promotes the reabsorption of renal water is increased in chronic heart failure. Here, we compared the effects of tolvaptan, a newly developed nonpeptide V(2) receptor antagonist, with those of furosemide, a loop diuretic, and a combination of these 2 agents in rats with left ventricular dysfunction after myocardial infarction (MI). METHODS AND RESULTS Af...

full text

Natural history of severe left ventricular dysfunction after myocardial infarction.

The prevalence and prognosis of severe left ventricular dysfunction after infarction was prospectively analyzed in a series of 259 male patients aged 60 years or less surviving an acute myocardial infarction. All patients underwent coronary angiography 30 days after the acute event and were followed up for a mean period of 34 months (range, 15 to 55 months). Forty-five patients (17 percent) wer...

full text

Left Ventricular Dysfunction (SOLVD)

Background Peak oxygen consumption is reduced in patients with symptomatic congestive heart failure, but functional capacity of patients with asymptomatic left ventricular systolic dysfunction has not been assessed by measurement of peak oxygen consumption attained during graded exercise testing. Methods and Results Peak oxygen consumption, that is, aerobic capacity (Vo2, mL/kg per minute), was...

full text

Left Ventricular Dysfunction (SOLVD)

Neuroendocrine activation is known to occur in patients with congestive heart failure, but there is uncertainty as to whether this occurs before or after the presence of overt symptoms. In the Studies of Left Ventricular Dysfunction (SOLVD), a multicenter study of patients with ejection fractions of 35% or less, we compared baseline plasma norepinephrine, plasma renin activity, plasma atrial na...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 26  issue 1

pages  54- 57

publication date 2018-01-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023